Steroids in Lupus: Enemies or Allies.

Area of Science:

• Immunology
• Rheumatology
• Pharmacology

Background:

• Glucocorticoids are primary treatments for inflammatory and autoimmune diseases, including systemic lupus erythematosus (SLE).
• While effective in managing symptoms and reducing mortality, glucocorticoids are associated with dose- and duration-limiting side effects.
• Systemic lupus erythematosus (SLE) is a complex autoimmune condition requiring multifaceted treatment strategies, often including corticosteroids.

Purpose of the Study:

• To critically review the existing literature on the therapeutic benefits of glucocorticoids in managing inflammatory and autoimmune diseases.
• To evaluate the spectrum of side effects and cumulative damage associated with glucocorticoid use, particularly in SLE.
• To provide a balanced perspective on the risk-benefit profile of glucocorticoids in clinical practice.

Main Methods:

• Comprehensive literature search of published studies on glucocorticoid therapy in inflammatory and autoimmune diseases.
• Critical analysis of evidence regarding efficacy, side effects, and long-term damage.
• Synthesis of findings to assess the overall impact of glucocorticoids.

Main Results:

• Glucocorticoids demonstrate potent anti-inflammatory and immunosuppressive effects, crucial for acute and chronic management of diseases like SLE.
• Significant evidence links glucocorticoid use to a range of adverse effects, including organ damage, impacting long-term patient outcomes.
• Despite emerging therapies, glucocorticoids remain a cornerstone of SLE treatment, necessitating careful management.

Conclusions:

• Glucocorticoids offer substantial benefits in controlling immune activation and inflammation but require judicious use due to associated risks.
• Understanding and mitigating glucocorticoid-induced damage is essential for optimizing patient care in autoimmune and inflammatory conditions.
• A balanced approach, weighing therapeutic advantages against potential harm, is critical when employing glucocorticoids.